Published in Wound Repair Regen on May 04, 2011
The role of the TGF-β family in wound healing, burns and scarring: a review. Int J Burns Trauma (2012) 1.74
Apoptosis and angiogenesis: an evolving mechanism for fibrosis. FASEB J (2013) 0.93
Pivotal role for decorin in angiogenesis. Matrix Biol (2015) 0.90
The alarmin HMGB-1 influences healing outcomes in fetal skin wounds. Wound Repair Regen (2013) 0.83
Tissue engineering and regenerative repair in wound healing. Ann Biomed Eng (2014) 0.80
Beta-Adrenoceptor Activation Reduces Both Dermal Microvascular Endothelial Cell Migration via a cAMP-Dependent Mechanism and Wound Angiogenesis. J Cell Physiol (2015) 0.79
The role of vascular endothelial growth factor in fractional laser resurfacing with the carbon dioxide laser. Lasers Med Sci (2011) 0.79
Pigment epithelium-derived factor as a multifunctional regulator of wound healing. Am J Physiol Heart Circ Physiol (2015) 0.76
Autologous Graft Thickness Affects Scar Contraction and Quality in a Porcine Excisional Wound Model. Plast Reconstr Surg Glob Open (2015) 0.75
Double knockout of Bax and Bak from kidney proximal tubules reduces unilateral urethral obstruction associated apoptosis and renal interstitial fibrosis. Sci Rep (2017) 0.75
Anti-Vascular Endothelial Growth Factor (Bevacizumab) Therapy Reduces Hypertrophic Scar Formation in a Rabbit Ear Wounding Model. Arch Plast Surg (2016) 0.75
Anti-Angiogenic Drugs: Involvement in Cutaneous Side Effects and Wound-Healing Complication. Adv Wound Care (New Rochelle) (2014) 0.75
Intralesional cryotherapy for treatment of keloid scars: a prospective study. Plast Reconstr Surg (2015) 3.26
The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation. Plast Reconstr Surg (2004) 3.14
The Use of Autologous Fat Grafting for Treatment of Scar Tissue and Scar-Related Conditions: A Systematic Review. Plast Reconstr Surg (2016) 3.13
Effectiveness of Autologous Fat Grafting in Adherent Scars: Results Obtained by a Comprehensive Scar Evaluation Protocol. Plast Reconstr Surg (2017) 3.04
Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res (2004) 3.03
Clinical effectiveness of dermal substitution in burns by topical negative pressure: a multicenter randomized controlled trial. Wound Repair Regen (2012) 2.78
Potential cellular and molecular causes of hypertrophic scar formation. Burns (2008) 2.39
Angiogenesis in synchronous and metachronous colorectal liver metastases: the liver as a permissive soil. Ann Surg (2012) 2.13
High-dose-rate brachytherapy for the treatment of recalcitrant keloids: a unique, effective treatment protocol. Plast Reconstr Surg (2014) 2.05
Macrophages in skin injury and repair. Immunobiology (2011) 2.00
Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis. Arthritis Rheum (2006) 1.98
Morphometry of dermal collagen orientation by Fourier analysis is superior to multi-observer assessment. J Pathol (2002) 1.98
RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature. Drug Resist Updat (2005) 1.98
Generating hypotheses by discovering implicit associations in the literature: a case report of a search for new potential therapeutic uses for thalidomide. J Am Med Inform Assoc (2003) 1.97
Human hypertrophic and keloid scar models: principles, limitations and future challenges from a tissue engineering perspective. Exp Dermatol (2014) 1.71
Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin. J Control Release (2003) 1.63
Prevention and curative management of hypertrophic scar formation. Burns (2008) 1.63
Pleiotropic effects of angiopoietin-2 deficiency do not protect mice against endotoxin-induced acute kidney injury. Nephrol Dial Transplant (2012) 1.55
Costs of burn care: a systematic review. Wound Repair Regen (2014) 1.49
Topical silicone gel versus placebo in promoting the maturation of burn scars: a randomized controlled trial. Plast Reconstr Surg (2010) 1.48
A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets. Bioconjug Chem (2004) 1.47
Bench-to-bedside review: Angiopoietin signalling in critical illness - a future target? Crit Care (2009) 1.45
Time course of angiopoietin-2 release during experimental human endotoxemia and sepsis. Crit Care (2009) 1.41
Adjunct nitrous oxide normalizes vascular reactivity changes after hemorrhagic shock in mice under isoflurane anesthesia. Anesthesiology (2009) 1.40
No efficacy for silicone gel sheeting in prevention of abnormal scar formation in children with cancer: a randomized controlled trial. Plast Reconstr Surg (2015) 1.39
Tumor vessel biology in pediatric intracranial ependymoma. J Neurosurg Pediatr (2010) 1.38
"Reply to: Effectiveness of autologous fat grafting in adherent scars: results obtained by a comprehensive scar evaluation protocol". Plast Reconstr Surg (2017) 1.38
Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy. Diabetes (2008) 1.36
Differential effects of NF-{kappa}B and p38 MAPK inhibitors and combinations thereof on TNF-{alpha}- and IL-1{beta}-induced proinflammatory status of endothelial cells in vitro. Am J Physiol Cell Physiol (2005) 1.32
Preparation and functional evaluation of RGD-modified proteins as alpha(v)beta(3) integrin directed therapeutics. Bioconjug Chem (2002) 1.22
A novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo. Hum Gene Ther (2004) 1.22
Scar assessment tools: implications for current research. Plast Reconstr Surg (2002) 1.21
Identification of epigenetically silenced genes in tumor endothelial cells. Cancer Res (2007) 1.20
Colour evaluation in scars: tristimulus colorimeter, narrow-band simple reflectance meter or subjective evaluation? Burns (2004) 1.19
Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGFβ2 in vascular abnormalization. J Pathol (2012) 1.16
Increased formation of pyridinoline cross-links due to higher telopeptide lysyl hydroxylase levels is a general fibrotic phenomenon. Matrix Biol (2004) 1.16
Biological background of dermal substitutes. Burns (2009) 1.15
In vivo characteristics of cationic liposomes as delivery vectors for gene therapy. Pharm Res (2002) 1.15
Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGF-I, bFGF and PDGF-AB compared to controls. Eur J Cell Biol (2002) 1.14
Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: An objective histopathological analysis. Wound Repair Regen (2009) 1.13
Collagen morphology in human skin and scar tissue: no adaptations in response to mechanical loading at joints. Burns (2003) 1.11
Epigenetic regulation of tumor endothelial cell anergy: silencing of intercellular adhesion molecule-1 by histone modifications. Cancer Res (2006) 1.11
Comparison between human fetal and adult skin. Arch Dermatol Res (2009) 1.10
Relationship between duration of brain death and hemodynamic (in)stability on progressive dysfunction and increased immunologic activation of donor kidneys. Kidney Int (2003) 1.10
Angiogenic transcriptome of human microvascular endothelial cells: Effect of hypoxia, modulation by atorvastatin. Vascul Pharmacol (2006) 1.08
Early organ-specific endothelial activation during hemorrhagic shock and resuscitation. Shock (2008) 1.07
Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice. Neoplasia (2005) 1.07
Allogeneic fibroblasts in dermal substitutes induce inflammation and scar formation. Wound Repair Regen (2002) 1.06
Skin elasticity meter or subjective evaluation in scars: a reliability assessment. Burns (2004) 1.05
Shock-induced stress induces loss of microvascular endothelial Tie2 in the kidney which is not associated with reduced glomerular barrier function. Am J Physiol Renal Physiol (2009) 1.04
Molecular pathways of endothelial cell activation for (targeted) pharmacological intervention of chronic inflammatory diseases. Curr Vasc Pharmacol (2005) 1.03
Freshly isolated stromal cells from the infrapatellar fat pad are suitable for a one-step surgical procedure to regenerate cartilage tissue. Cytotherapy (2009) 1.02
Targeting of RGD-modified proteins to tumor vasculature: a pharmacokinetic and cellular distribution study. Int J Cancer (2002) 1.02
RhoJ is an endothelial cell-restricted Rho GTPase that mediates vascular morphogenesis and is regulated by the transcription factor ERG. Blood (2011) 1.02
Differential response of human adipose tissue-derived mesenchymal stem cells, dermal fibroblasts, and keratinocytes to burn wound exudates: potential role of skin-specific chemokine CCL27. Tissue Eng Part A (2013) 1.01
The angiopoietin 1/angiopoietin 2 balance as a prognostic marker in primary glioblastoma multiforme. J Neurosurg (2009) 1.00
Dermal substitution in acute burns and reconstructive surgery: a 12-year follow-up. Plast Reconstr Surg (2010) 1.00
Detrimental dermal wound healing: what can we learn from the oral mucosa? Wound Repair Regen (2013) 0.99
Site-specific inhibition of glomerulonephritis progression by targeted delivery of dexamethasone to glomerular endothelium. Mol Pharmacol (2007) 0.99
Inhibition of proinflammatory genes in anti-GBM glomerulonephritis by targeted dexamethasone-loaded AbEsel liposomes. Am J Physiol Renal Physiol (2007) 0.99
FOXO3 modulates endothelial gene expression and function by classical and alternative mechanisms. J Biol Chem (2010) 0.98
Adaptation of the dermal collagen structure of human skin and scar tissue in response to stretch: an experimental study. Wound Repair Regen (2012) 0.97
Angiogenic endothelium shows lactadherin-dependent phagocytosis of aged erythrocytes and apoptotic cells. Blood (2008) 0.96
Microvascular endothelial cell heterogeneity: general concepts and pharmacological consequences for anti-angiogenic therapy of cancer. Cell Tissue Res (2008) 0.96
Rational design of RGD-albumin conjugates for targeted delivery of the VEGF-R kinase inhibitor PTK787 to angiogenic endothelium. ChemMedChem (2006) 0.96
Rasch analysis of the Patient and Observer Scar Assessment Scale (POSAS) in burn scars. Qual Life Res (2011) 0.95
The flow dependency of Tie2 expression in endotoxemia. Intensive Care Med (2013) 0.95
Evaluation of RGD-targeted albumin carriers for specific delivery of auristatin E to tumor blood vessels. Bioconjug Chem (2006) 0.95
Improved efficacy of alphavbeta3-targeted albumin conjugates by conjugation of a novel auristatin derivative. Mol Pharm (2007) 0.95
Culture of keratinocytes for transplantation without the need of feeder layer cells. Cell Transplant (2007) 0.95
New dermal substitutes. Wound Repair Regen (2011) 0.95
The angiogenic makeup of human hepatocellular carcinoma does not favor vascular endothelial growth factor/angiopoietin-driven sprouting neovascularization. Hepatology (2008) 0.93
Vascular bed-specific regulation of the von Willebrand factor promoter in the heart and skeletal muscle. Blood (2010) 0.93
Wound healing in a fetal, adult, and scar tissue model: a comparative study. Wound Repair Regen (2010) 0.93
Selective intracellular delivery of dexamethasone into activated endothelial cells using an E-selectin-directed immunoconjugate. J Immunol (2002) 0.92
Recurrence of plantar fibromatosis after plantar fasciectomy: single-center long-term results. Plast Reconstr Surg (2008) 0.92
Oral carnosine supplementation prevents vascular damage in experimental diabetic retinopathy. Cell Physiol Biochem (2011) 0.92
Adiponectin diminishes organ-specific microvascular endothelial cell activation associated with sepsis. Shock (2012) 0.91
Collagen bundle morphometry in skin and scar tissue: a novel distance mapping method provides superior measurements compared to Fourier analysis. J Microsc (2011) 0.90
Acceptance of vaccination during pregnancy: experience with 2009 influenza A (H1N1) in the Netherlands. Vaccine (2012) 0.90
Postoperative pressure therapy of ear keloids using a custom-made methyl methacrylate stent. Dermatol Surg (2010) 0.90
Formation of hypertrophic scars: evolution and susceptibility. J Plast Surg Hand Surg (2012) 0.89
Acceptability of different oral formulations in infants and preschool children. Arch Dis Child (2013) 0.88
Interactions between blood-borne Streptococcus pneumoniae and the blood-brain barrier preceding meningitis. PLoS One (2013) 0.88
Delivery of the p38 MAPkinase inhibitor SB202190 to angiogenic endothelial cells: development of novel RGD-equipped and PEGylated drug-albumin conjugates using platinum(II)-based drug linker technology. Bioconjug Chem (2006) 0.88
Burns to the head and neck: Epidemiology and predictors of surgery. Burns (2013) 0.87
Collagen cross-linking by adipose-derived mesenchymal stromal cells and scar-derived mesenchymal cells: Are mesenchymal stromal cells involved in scar formation? Wound Repair Regen (2009) 0.87